(KRTX) – Analyst Ratings
-
Karuna Therapeutics Inc. (KRTX) PT Raised to $260 at Stifel
-
Karuna Therapeutics Inc. (KRTX) Surges After Trial Meets Primary Endpoint
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to KRTX Stock Lookup